prospective study, we allowed every patient experience with machine in form of test stimuli before starting the test and we would only start the real test once the patient feels comfortable with the whole procedure. We feel lack of familiarity with the machine will affect the mean retinal sensitivity. The authors have not mentioned the initial level of sensitivity they used as the MP 1 allows the examiner to select this setting before test is initiated. This is important as in patients with diabetic macular oedema with mean sensitivity of 2 dB. If the test was started at 16 dB, then it would take a longer time to complete the test. The prolonged time could result in decreased patient cooperation parameters such as false-positives or fixation stability and these parameters have not been reported in this study. This data would be helpful in interpreting the reliability of the results.
Sir, Response to Shah and Chalam
We appreciate the interest of Drs Shah and Chalam in our article and thank them for their comments. Our study was a pilot study to examine how the retinal sensitivity measured with the MP-1 correlates with other parameters, such as retinal thickness and visual acuity. From our experience, we feel that the testing conditions should be further modified especially for patients with poor visual acuity. In this study, the age of diabetic patients ranged from 25 to 76 years, and that of the controls from 42 to 76 years, as described in the Subjects and methods section. The reduced sensitivity may be due to the ages of the normal subjects. All tests were performed in a lighted room. In order to obtain more reliable data from patients with poor VA, we used a larger cross for fixation, and allow patients to learn the test. We also appreciate the other suggestions for further studies.
